Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01271686 · ClinicalTrials.gov registry record · Phase 4
24-hour IOP-lowering Effect of 0.01% Bimatoprost
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01271686 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 16 participants.
The verdict
NCT01271686, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will evaluate the 24-hour IOP-lowering efficacy of 0.01% bimatoprost once daily in patients with glaucoma or ocular hypertension
Interventions
- DRUG 0.01% bimatoprost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01271686
The ClinicalTrials.gov registry entry for NCT01271686 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 0.01% bimatoprost is the first listed.
NCT01271686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01271686 about?
NCT01271686 is a clinical study titled "24-hour IOP-lowering Effect of 0.01% Bimatoprost". This study will evaluate the 24-hour IOP-lowering efficacy of 0.01% bimatoprost once daily in patients with glaucoma or ocular hypertension
What is the current status of trial NCT01271686?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2011-01. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01271686?
The interventions under investigation include: 0.01% bimatoprost (DRUG).
Who is sponsoring clinical trial NCT01271686?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.